Literature DB >> 31321458

The use of reaction time distributions to study attention in male rats: the effects of atomoxetine and guanfacine.

Zach V Redding1, Pooja Chawla2, Karen E Sabol3.   

Abstract

RATIONALE: Norepinephrine (NE) is involved in the control of sustained attention. Studies of sustained attention in humans include measures of reaction time (RT) and RT variability (RTV). The present study tested the role of NE using components of the RT distribution in rats in a manner thought to be similar to human studies of RTV.
OBJECTIVES: This study tested the effects of increased synaptic NE (atomoxetine (ATX)) and α-2 receptor binding (guanfacine) on attentional lapses in rats.
METHODS: Male Sprague-Dawley rats (n = 20) were trained and tested in a two-choice RT task (2CRTT). Atomoxetine dose (saline, 0.1, 0.5, 1.0 mg/kg, i.p.), guanfacine dose (saline, 0.01, 0.1, 0.3 mg/kg, i.p.), and distractors were manipulated in three experiments. RT was divided into initiation time (IT) and movement time (MT). Analyses of distribution mode (peak) and deviation from the mode (skew) were then performed.
RESULTS: ATX and guanfacine had no effect on IT mode, reduced IT devmode, and increased MT mode. When distractors were introduced, ATX again improved devmode, but a lack of interaction between ATX and distractor indicated that ATX did not prevent distractor-induced impairments.
CONCLUSIONS: IT devmode is a measure of distribution skew thought to reflect lapses of attention. The effects of ATX on IT devmode suggest that increased synaptic NE reduces attentional lapses. These findings are consistent with human reports of reduced RTV after ATX administration. The same pattern of results with guanfacine suggests that the effects of increased NE are due in part to binding at α-2 noradrenergic receptors.

Entities:  

Keywords:  ADHD; Atomoxetine; Distractors; Distribution skew; Guanfacine; Lapses of attention; Norepinephrine; Rat; Reaction time variability; α-2 noradrenergic receptors

Mesh:

Substances:

Year:  2019        PMID: 31321458     DOI: 10.1007/s00213-019-05329-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  64 in total

1.  A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.

Authors:  L Scahill; P B Chappell; Y S Kim; R T Schultz; L Katsovich; E Shepherd; A F Arnsten; D J Cohen; J F Leckman
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

Review 2.  Reaction time variability in ADHD: a meta-analytic review of 319 studies.

Authors:  Michael J Kofler; Mark D Rapport; Dustin E Sarver; Joseph S Raiker; Sarah A Orban; Lauren M Friedman; Ellen G Kolomeyer
Journal:  Clin Psychol Rev       Date:  2013-06-13

3.  The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes.

Authors:  A F Arnsten; J X Cai; P S Goldman-Rakic
Journal:  J Neurosci       Date:  1988-11       Impact factor: 6.167

Review 4.  Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis.

Authors:  Simona Ruggiero; Antonio Clavenna; Laura Reale; Annalisa Capuano; Francesco Rossi; Maurizio Bonati
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-11       Impact factor: 4.600

5.  Dimensional analysis of ADHD subtypes in rats.

Authors:  Candice Blondeau; Françoise Dellu-Hagedorn
Journal:  Biol Psychiatry       Date:  2006-10-19       Impact factor: 13.382

6.  Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.

Authors:  Neil E Paterson; Jennifer Ricciardi; Caitlin Wetzler; Taleen Hanania
Journal:  Neurosci Res       Date:  2010-10-08       Impact factor: 3.304

Review 7.  The attention system of the human brain: 20 years after.

Authors:  Steven E Petersen; Michael I Posner
Journal:  Annu Rev Neurosci       Date:  2012-04-12       Impact factor: 12.449

8.  Effects of atomoxetine and methylphenidate on performance of a lateralized reaction time task in rats.

Authors:  J David Jentsch; Shawn M Aarde; Emanuele Seu
Journal:  Psychopharmacology (Berl)       Date:  2008-06-06       Impact factor: 4.530

9.  Atomoxetine Treatment Strengthens an Anti-Correlated Relationship between Functional Brain Networks in Medication-Naïve Adults with Attention-Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Clinical Trial.

Authors:  Hsiang-Yuan Lin; Susan Shur-Fen Gau
Journal:  Int J Neuropsychopharmacol       Date:  2015-09-16       Impact factor: 5.176

10.  Differential roles for cortical versus sub-cortical noradrenaline and modulation of impulsivity in the rat.

Authors:  Abigail Benn; Emma S J Robinson
Journal:  Psychopharmacology (Berl)       Date:  2016-10-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.